Inhibitory effects of morinda officinalis extract on bone loss in ovariectomized rats

Molecules

Volumn 14, Issue 6, 2009, Pages 2049-2061

  Li, Nan ^a   Qin, Lu Ping ^a   Han, Ting ^a   Wu, Yan Bin ^a   Zhang, Qiao Yan ^a,b   Zhang, Hong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Bone mineral density; Morinda officinalis; Osteoporosis; Ovariectomy; Serum biochemistry

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCIUM; CORTICOSTERONE; CORTICOTROPIN; INTERLEUKIN 6; ISOENZYME; OSTEOPROTEGERIN; PHOSPHORUS; PLANT EXTRACT; TARTRATE-RESISTANT ACID PHOSPHATASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; BONE DENSITY; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MORINDA; ORGAN SIZE; OVARIECTOMY; RAT; SPRAGUE DAWLEY RAT;

ACID PHOSPHATASE; ADRENOCORTICOTROPIC HORMONE; ANIMALS; BODY WEIGHT; BONE DENSITY; CALCIUM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTICOSTERONE; FEMALE; INTERLEUKIN-6; ISOENZYMES; MOLECULAR STRUCTURE; MORINDA; ORGAN SIZE; OSTEOPROTEGERIN; OVARIECTOMY; PHOSPHORUS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67649886666     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14062049     Document Type: Article

References (40)

1. Jee, W.S.S.; Yao, W. Overview: animal models of osteopenia and osteoporosis. J. Musculoskel. Neuronal Interact. 2001, 1, 193-207.
2. Rossouw, J.E.; Anderson, G.L.; Prentice, R.L. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. J. Am. Med. Assoc. 2002, 288, 321-333.
3. National Pharmacopoeia Commission of P.R. China. Pharmacopoeia of the People's Republic of China 2005; Volume 1, p. 55.
4. Zhang, Z.Q.; Li, Y.; Yang, M.; Luo, Z.P.; Zhao, Y.M. The effect of Morinda officinalis How, a Chinese traditional medicinal plant, on the DRL 72-s schedule in rats and the forced swimming test in mice. Pharmacol. Biochemi. Behavi. 2002, 72, 39-43.
5. Wang, H.M.; Wang, L.; Li, N. Effect of Morinda Officinalis on the expression of cbfa1 during the differentiation from BMSCs to the osteoblast. Chine. J. Trad. Med. 2004, 12, 22-27.
6. Li, N.; Wang, H.M.; Lin, X.; Zheng, L.P.; Shen, L.; Wang, L.; Chen, B.Y. Experimental study on effects of Radix Morinda Officinalis on biological specialty of osteoblast. Zhong Guo Yi Yao Xue Bao 2004, 19, 726-728.
7. Seo, B.; Ku, S.K.; Cha, E.M.; Park, J.H.; Kim, J.D.; Choi, H.Y.; Lee, H.S. Effect of Mornidae Radix extracts on experimental esteoporosis in sciatic neurectomized mice. Phytother. Res. 2005, 19, 231-238.
8. Wu, Y.B.; Zheng, C.J.; Qin, L.P.; Sun, L.N.; Han, T.; Jiao, L.; Zhang, Q.Y.; Wu, J.Z.
9. Antiosteoporotic activity of anthraquinones from Morinda officinalis on osteoblast and osteoclasts. Molecules 2009, 14, 573-583.
10. Kimmel, D.B. Animal models for in vivo experimentation in osteoporosis research. In Osteoporosis; Marcus, R., Feldman, D., Kelsey, J., Eds.; Academic Press: San Diego, CA, USA, 1996; pp. 671-690.
11. Branca, F. Dietary phyto-oestrogens and bone health. Proc. Nutr. Soc. 2003, 62, 877-887.
12. Ohlsson, C.; Hellberg, N.; Parini, P. Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem. Biophys. Res. Commun. 2000, 275, 640-645.
13. Anwar, A.; McTernan, P.G.; Anderson, L.A. Site-specific regulation of oestrogen receptor-alpha and -beta by oestradiol in human adipose tissue. Diabetes Obes. Metab. 2001, 3, 338-349.
14. Pedersen, S.B.; Bruun, J.M.; Hube, F.; Kristensen, K.; Hauner, H.; Richels, B. Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: Influences of adipose cell differentiation and fat depot localization. Mol. Cell Endocrinol. 2001, 152, 27-37.
15. Mokbel, K. Risk-reducing strategies for breast cancer--a review of recent literature. Int. J. Fertil Womens Med. 2003, 45, 274-277.
16. Smith, R.E. A review of selective estrogen receptor modulators and national surgical adjuvant breast and bowel project clinical trials. Semin. Oncol. 2003, 30, 4-13.
17. Beck, V.; Rohr, U.; Jungbauer, A. Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy. J. Steroid Biochem. Mol. Biol. 2005, 94, 499-518.
18. Kalu, D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 1991, 15, 175-191.
19. Yilmaz, B.; Seyran, A.D.; Sandal, S.; Aydin, M.; Colakoglu, N.; Kocer, M.; Carpenter, D.O. Modulatory effects of Aroclors 1221 and 1254 on bone turnover and vertebral histology in intact and ovariectomized rats. Toxicol. Lett. 2006, 166, 276-284.
20. Erben, R.G.; Brunner, K.S.; Breig, B. Long-term sensitivity of uterus and hypothalamus/pituitary axis to 17-beta-estradiol is higher than that of bone in rats. J. Bone Miner Res. 2004, 19, 1827-1832.
21. Das, A.S.; Das, D.; Mukherjee, M.; Mukherjee, S.; Mitra, C. Phytoestrogenic effects of black tea extract (Camellia sinensis) in an oophorectomized rat (Rattus norvegicus) model of osteoporosis. Life Sci. 2005, 77, 3049-3057.
22. Annie, S.; Prabhua, R.G.; Malini, S. Activity of Wedelia calendulacea Less. In post-menopausal osteoporosis. Phytomedicine 2006, 13, 43-48.
23. Raisz, L.G. Local and systemic factors in the pathogenesis of osteoporosis. N. Eng. J. Med. 1988, 315, 818-828.
24. Teitelbaum, S.L. Bone resorption by osteoclasts. Science 2000, 259, 1504-1508.
25. Jilka, R.L.; Hangoc, G.; Girasole, G.; Passeri, G.; Williams, D.C.; Abrams, J.S.; Boyce, B.; Broxmeyer, H.; Manolagas, S.C. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992, 257, 88-91.
26. Kobayashi, K.; Takahashi, N.; Jimi, E.; Udagawa, N.; Takami, M.; Kotake, S. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 2000, 191, 275-286.
27. Zhu, M.Y.; Wang, C.J.; Zhang, H.S.; Pei, X.W.; Fen, J.M. Protective effect of polysaccharides from morinda officinalis on bone loss in ovariectomized rats. Int. J. Biol. Macromol. 2008, 43, 276-278.
28. Yasuda, H.; Shima, N.; Nakagawa, N.; Yamaguchi, K.; Kinosaki, M.; Mochizuki, S.; Tomoyasu, A.; Yano, K.; Goto, M.; Murakami, A.; Tsuda, E.; Morinaga, T.; Higashio, K.; Udagawa, N.; Takahashi, N.; Suda, T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 1998, 95, 3597-3602.
29. Hofbauer, L.C.; Dunstan, C.R.; Spelsberg, T.C.; Riggs, B.L. Khosla, S. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem. Biophys. Res. Commun. 1998, 250, 776-781.
30. Hofbauer, L.C.; Lacey, D.L.; Dunstan, C.R.; Spelsberg, T.C.; Riggs, B.L.; Khosla, S. Interleukin- 1β and tumor necrosis factor-α, but not interleukin-6 stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 1999, 25, 255-259.
31. Wang, L.; Mao, Y.J.; Wang, W.J. Inhibitory effect of diacere in on osteoclastic bone destruction and its possible mechan ism of action. Acta Pharm. Sin.2006, 41, 555-560.
32. Niyomchai, T.; Russo, S.J.; Festa, E.D.; Akhavan, A.; Jenab, S.; Vanya, Q.J.T. Progesterone inhibits behavioral responses and estrogen increases corticosterone levels after acute cocaine administration. Pharmacol. Biochem. Behav. 2005, 80, 603-610.
33. Burgess, L.H.; Handa, R.J. Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion and glucocorticoid receptor-mediated functions in female Rats. Endocrinol. 1992, 131, 1261-1269.
34. Fitch, R.H.; McGivern, R.F.; Redei, E.; Schrott, L.M.; Cowell, P.E.; Denenberg, V.H. Neonatal ovariectomy and pituitary-adrenal responsiveness in the adult rat. Acta Endocrinol. 1992, 126, 44-48.
35. Kitay, J.I. Effects of oestradiol on pituitary-adrenal function in male and female rats. Endocrinology 1963, 72, 947-954.
36. Rosenberg, S.V.; Wehr, U.; Bachmann, H. Effect of vitamin D-containing plant extracts on osteoporotic bone. J. Steroid Biochem. Mol. Biol. 2007, 103, 596-600.
37. Boland, R.; Skliar, M.; Curino, A.; Milanesi, L. Vitamin D compounds in plants. Plant Sci. 2003, 1, 1-13.
38. Weissenberg, M.; Maoz, A.; Levy, A.; Wasserman, R.H. Radioimmunoassay for rapid estimation of vitamin D derivatives in calcinogenic plants. Planta Med. 1988, 54, 63-65.
39. Annie, S.; Prabhu, R.G.; Malini, S. Activity of Wedelia calendulacea Less. in post-menopausal osteoporosis. Phytomedicine 2006, 13, 43-48.
40. Branca, F. Dietary phyto-oestrogens and bone health. Proc. Nutr. Soc. 2003, 62, 877-887.